-
公开(公告)号:EP4504747A1
公开(公告)日:2025-02-12
申请号:EP23781859.6
申请日:2023-03-31
Applicant: National Taiwan University
Inventor: LIANG, Pi-Hui
-
公开(公告)号:EP4397366A3
公开(公告)日:2024-11-20
申请号:EP24159204.7
申请日:2018-08-06
Applicant: Ardelyx, Inc.
Inventor: LUEHR, Gary , DRAGOLI, Dean , LEADBETTER, Michael , CHEN, Tao , LEWIS, Jason
IPC: C07J63/00 , A61K31/575 , A61P3/12 , A61P7/08
Abstract: The present invention provides a compound of formula (I) or a salt thereof: (I) wherein X, L, V, R 1 , R 2 , R 3 and R 4 , are as defined herein. These compounds are inhibitors of 11-hydroxysteroid dehydrogenase type 2 (11-HSD-2) and are used to treat hyperkalemia.
-
公开(公告)号:EP3661945B1
公开(公告)日:2024-04-03
申请号:EP18759491.6
申请日:2018-08-06
Inventor: LUEHR, Gary , DRAGOLI, Dean , LEADBETTER, Michael , CHEN, Tao , LEWIS, Jason
IPC: C07J63/00 , A61K31/575 , A61P5/44
-
公开(公告)号:EP4248960A3
公开(公告)日:2024-01-03
申请号:EP23190310.5
申请日:2020-02-11
Applicant: Hetero Labs Limited
Inventor: BANDI, Parthasaradhi Reddy , KURA, Rathnakar Reddy , ABDULLA, Panduranga Reddy , KASIREDDY, Bhaskar Reddy
Abstract: The present invention relates to novel triterpene derivatives of formula (I); and pharmaceutically acceptable salts thereof, wherein R 1 , R 2 , R 3 , R 4 , and ring
are as defined herein. The invention also relates to novel triterpene derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.-
公开(公告)号:EP3686212B1
公开(公告)日:2023-11-01
申请号:EP18856706.9
申请日:2018-09-17
Inventor: NAN, Fajun , XIE, Xin , XIE, Cen , ZHANG, Chenlu , LIU, Yameng , GUO, Shimeng , ZHANG, Yangming , WANG, Siwei
-
公开(公告)号:EP4234016A3
公开(公告)日:2023-10-18
申请号:EP23164821.3
申请日:2020-02-06
Applicant: Ardelyx, Inc.
Inventor: DRAGOLI, Dean , LUEHR, Gary , CHEN, Tao , LEWIS, Jason , LEADBETTER, Michael
Abstract: The present invention provides a compound of formula (I) or a salt thereof:
wherein X, L, V, R 1 , R 2 , R 3 and R 4 , are as defined herein. The claimed compounds inhibit the enzyme 11-hydroxysteroid dehydrogenase type 2 (11-HSD2) and as a result are useful in the treatment of hyperkalemia by preventing cortisol from being oxidised to cortisone and thus allowing it to occupy the mineralocorticoid receptor, thus stimulating potassium excretion-
公开(公告)号:EP4015003B1
公开(公告)日:2023-05-10
申请号:EP21212184.2
申请日:2019-12-09
Inventor: POSTEL, Ruben , FUCHS, Hendrik
-
公开(公告)号:EP3389669B1
公开(公告)日:2023-03-15
申请号:EP16876910.7
申请日:2016-12-19
Inventor: TAN, Derek S. , GIN, David Y. , WALKOWICZ, William E. , FERNANDEZ-TEJADA, Alberto , RAGUPATHI, Govindaswami
IPC: C07J63/00 , A61K31/7024
-
公开(公告)号:EP3990468A1
公开(公告)日:2022-05-04
申请号:EP20743477.0
申请日:2020-06-29
Applicant: Sage Therapeutics, Inc.
-
公开(公告)号:EP3990467A1
公开(公告)日:2022-05-04
申请号:EP20743025.7
申请日:2020-06-29
Applicant: Sage Therapeutics, Inc.
-
-
-
-
-
-
-
-
-